Rand Capital Q3 2026: NII Falls to $0.23/Share, Controls Flagged Not Effective
RAND is trading near its 52-week low of $9.11 (7.0% above the low).
Summary
Rand Capital's Q3 2026 10-Q shows investment income down 17% to $1.3 million and net investment income of $0.23 per share as four portfolio companies sit on non-accrual, with cash down to $223,000 and $5.0 million drawn on the credit line. The filing also states disclosure controls were not effective at quarter-end due to the previously disclosed income-tax material weakness.
Key Events · Earnings and Guidance · RAND
-
Q3 Investment Income Falls 17%
Total investment income was $1,311,768 versus $1,579,623 a year earlier, and net investment income was $668,941, or $0.23 per share, down from $0.33.
-
Four Portfolio Companies on Non-Accrual
Autotality, FSS, ITA and MRES are on non-accrual, with $20.7 million of cost and $8.7 million of fair value — 31.7% and 15.3% of the portfolio — pulling the debt yield to 8.97% from 11.3% at December 31, 2025.
-
Controls Not Effective on Tax Weakness
Management concluded disclosure controls and procedures were not effective at September 30, 2026 because of the material weakness in income-tax accounting previously disclosed in the 2025 10-K; remediation is underway but not yet validated.
-
Liquidity Tightens, Credit Line Drawn
Cash fell to $222,920 from $4,208,948 at year-end, with $5.0 million outstanding on the $25 million M&T facility and roughly $12.4 million of unused availability; the facility matures June 27, 2027.
Analysis · RAND · Unknown
The quarter was weak: total investment income fell 17% to $1.3 million and net investment income dropped to $669,000 ($0.23 per share) from $0.33 a year ago, because four portfolio companies (Autotality, FSS, ITA and MRES) are now on non-accrual, cutting interest income and pushing the debt yield down to 8.97% from 11.3% at year-end. NAV per share held roughly flat at $17.36, but liquidity is thin — cash is down to $223,000 with $5.0 million drawn on the credit line and only about $12.4 million of unused availability. The bigger governance item is the 10-Q's own conclusion that disclosure controls were not effective at September 30, 2026 because of the income-tax material weakness previously disclosed in the 2025 10-K; management says remediation is underway but the weakness is not yet considered fixed. For a small BDC trading well below NAV, a shrinking earnings base plus an unresolved control gap is the combination that matters.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RAND was trading at $9.75 on NASDAQ in the Unknown sector, with a market capitalization of approximately $29M. The 52-week trading range was $9.11 to $17.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.